Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter Archive
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter Archive
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Tags
Dupilumab
Tag: dupilumab
Dupilumab Lowered IgE Levels in Small Study
Dave Bloom
-
2025/03/17
0
Study Finds Biologic Drug Highly Effective in Reducing Pediatric Eczema Symptoms
News Wire ~ 3rd Party Press Release
-
2022/09/19
0
Dupixent® Phase 3 Trial Shows Positive Results in Children Ages 1-11...
News Wire ~ 3rd Party Press Release
-
2022/07/15
0
FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...
News Wire ~ 3rd Party Press Release
-
2022/05/23
0
FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12...
News Wire ~ 3rd Party Press Release
-
2022/04/12
0
CHOP Receives $2M Philanthropic Gift to Launch Food Allergy Study Using...
Dave Bloom
-
2021/11/18
0
Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and...
News Wire ~ 3rd Party Press Release
-
2020/10/26
0
FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...
News Wire ~ 3rd Party Press Release
-
2020/05/28
0
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
News Wire ~ 3rd Party Press Release
-
2019/03/12
0
Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...
News Wire ~ 3rd Party Press Release
-
2018/10/15
0
1
2
Page 1 of 2